Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $74,835 | 66 | 74.3% |
| Food and Beverage | $15,514 | 778 | 15.4% |
| Travel and Lodging | $5,720 | 26 | 5.7% |
| Consulting Fee | $4,538 | 4 | 4.5% |
| Education | $93.99 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $44,034 | 69 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $40,714 | 83 | $0 (2024) |
| Boston Scientific Corporation | $2,943 | 33 | $0 (2024) |
| Medtronic Vascular, Inc. | $2,125 | 39 | $0 (2020) |
| Amgen Inc. | $1,385 | 70 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $1,381 | 172 | $0 (2023) |
| Abbott Laboratories | $1,327 | 42 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $1,097 | 65 | $0 (2024) |
| ABIOMED | $703.27 | 12 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $609.46 | 49 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,402 | 42 | Lilly USA, LLC ($7,308) |
| 2023 | $6,905 | 41 | Lilly USA, LLC ($5,305) |
| 2022 | $16,358 | 103 | Lilly USA, LLC ($8,837) |
| 2021 | $9,756 | 86 | Boehringer Ingelheim Pharmaceuticals, Inc. ($6,697) |
| 2020 | $10,086 | 56 | Boehringer Ingelheim Pharmaceuticals, Inc. ($6,202) |
| 2019 | $28,237 | 224 | Lilly USA, LLC ($16,734) |
| 2018 | $17,913 | 202 | Boehringer Ingelheim Pharmaceuticals, Inc. ($10,943) |
| 2017 | $2,044 | 123 | BOSTON SCIENTIFIC CORPORATION ($372.19) |
All Payment Transactions
877 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: Not Applicable | ||||||
| 10/16/2024 | Medtronic, Inc. | FFRANGIO (Device) | Food and Beverage | In-kind items and services | $0.64 | General |
| Category: Fractional Flow Reserve (FFR) Systems | ||||||
| 08/30/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $21.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/25/2024 | Boston Scientific Corporation | OptiCross (Device) | Food and Beverage | In-kind items and services | $142.33 | General |
| Category: OptiCross_IC | ||||||
| 07/24/2024 | Medtronic, Inc. | AZURE XT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: Pacemakers | ||||||
| 07/17/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Not Applicable | ||||||
| 07/16/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $6.26 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 07/15/2024 | Medtronic, Inc. | AZURE XT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $5.46 | General |
| Category: Pacemakers | ||||||
| 06/24/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Renal Denervation System | ||||||
| 06/21/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/20/2024 | Medtronic, Inc. | AZURE XT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: Pacemakers | ||||||
| 06/20/2024 | Medtronic, Inc. | AZURE XT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $5.36 | General |
| Category: Pacemakers | ||||||
| 05/29/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $9.52 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 05/07/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Renal Denervation System | ||||||
| 04/15/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: Diabetes | ||||||
| 04/01/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $4.68 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 03/27/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $7.12 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 03/22/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $880.00 | General |
| Category: Diabetes | ||||||
| 03/21/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $121.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $880.00 | General |
| Category: Diabetes | ||||||
| 03/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $670.00 | General |
| Category: Diabetes | ||||||
| 03/15/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Travel and Lodging | Cash or cash equivalent | $124.62 | General |
| Category: Diabetes | ||||||
| 03/15/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Travel and Lodging | Cash or cash equivalent | $64.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 2,340 | 4,544 | $589,068 | $216,426 |
| 2022 | 32 | 2,230 | 3,920 | $544,538 | $189,205 |
| 2021 | 39 | 2,702 | 4,499 | $666,121 | $221,002 |
| 2020 | 39 | 2,480 | 4,374 | $683,003 | $187,902 |
All Medicare Procedures & Services
141 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 558 | 996 | $185,256 | $85,633 | 46.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 149 | 149 | $57,514 | $19,992 | 34.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 64 | 66 | $51,282 | $13,395 | 26.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 90 | 91 | $22,204 | $8,942 | 40.3% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 22 | 22 | $24,904 | $8,603 | 34.5% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 17 | 21 | $26,502 | $7,905 | 29.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 86 | 124 | $15,996 | $7,428 | 46.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 104 | 104 | $19,136 | $7,087 | 37.0% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 111 | 307 | $22,104 | $6,944 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 83 | 90 | $11,250 | $6,037 | 53.7% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 50 | 691 | $20,039 | $5,377 | 26.8% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 15 | 94 | $6,956 | $5,329 | 76.6% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 110 | 304 | $17,632 | $4,929 | 28.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 389 | 424 | $19,928 | $4,263 | 21.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 81 | 100 | $7,100 | $3,746 | 52.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 16 | 16 | $4,848 | $3,376 | 69.6% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 46 | 47 | $5,685 | $2,749 | 48.4% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 12 | 12 | $11,928 | $2,504 | 21.0% |
| 85610 | Blood test, clotting time | Office | 2023 | 44 | 488 | $7,320 | $2,025 | 27.7% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 16 | 16 | $12,080 | $1,907 | 15.8% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 15 | 94 | $5,546 | $1,853 | 33.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 28 | 28 | $10,808 | $1,291 | 11.9% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 120 | 129 | $8,772 | $1,221 | 13.9% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 12 | 13 | $5,720 | $1,079 | 18.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 13 | 13 | $1,651 | $809.51 | 49.0% |
About Dr. Gregory San, M.D
Dr. Gregory San, M.D is a Cardiovascular Disease healthcare provider based in Greenville, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1679565279.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory San, M.D has received a total of $100,701 in payments from pharmaceutical and medical device companies, with $9,402 received in 2024. These payments were reported across 877 transactions from 41 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($74,835).
As a Medicare-enrolled provider, San has provided services to 9,752 Medicare beneficiaries, totaling 17,337 services with total Medicare billing of $814,534. Data is available for 4 years (2020–2023), covering 141 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Greenville, SC
- Active Since 08/19/2005
- Last Updated 02/12/2010
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1679565279
Products in Payments
- JARDIANCE (Drug) $84,447
- CROSSBOSS (Device) $1,632
- XARELTO (Drug) $1,403
- HawkOne (Device) $1,320
- ENTRESTO (Drug) $993.65
- Repatha (Biological) $833.80
- Impella (Device) $703.27
- Resolute (Device) $620.76
- LifeVest (Device) $609.46
- Corlanor (Drug) $550.72
- PRALUENT (Drug) $355.58
- VERQUVO (Drug) $338.94
- Kerendia (Drug) $297.83
- ELIQUIS (Drug) $283.37
- Xience V coronary stent system (Device) $236.46
- Xience Sierra Coronary Stent System (Device) $211.10
- WATCHMAN (Device) $210.95
- PRADAXA (Drug) $200.70
- BRILINTA (Drug) $197.53
- AVVIGO Guidance System (Device) $179.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Greenville
Dr. Paul Mahoney, Md, MD
Cardiovascular Disease — Payments: $2.0M
Peter Netzler, M.d, M.D
Cardiovascular Disease — Payments: $299,810
Joseph Manfredi, Md, MD
Cardiovascular Disease — Payments: $287,712
Dr. Gregory Harris, Md, Phd, MD, PHD
Cardiovascular Disease — Payments: $192,161
Dr. Rajasekhar Nekkanti, Md, MD
Cardiovascular Disease — Payments: $124,359
Jeffrey Senfield, Md, MD
Cardiovascular Disease — Payments: $112,019